UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of report (date of earliest event reported): July 17, 2006
Phibro Animal Health Corporation
(Exact name of registrant as specified in its charter)
New York 333-64641 13-1840497
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
65 CHALLENGER ROAD
RIDGEFIELD PARK, NEW JERSEY 07660
(Address of principal executive offices) (Zip Code)
(201) 329-7300
Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 8.01
Phibro Animal Health Corporation and PAHC Holdings Corporation
(affiliated companies) issued a joint press release on July 17, 2006 announcing
the receipt of the requisite number of consents and tenders by holders of a
majority in aggregate principal amount of the following securities that are the
subject of ongoing offers to purchase and the solicitation of consents for
certain amendments to the indentures governing such securities:
13% Senior Secured Notes due 2007
9-7/8% Senior Subordinated Notes due 2008
15% Senior Secured Notes due 2010
In addition, the press release announced the total consideration for
each $1,000.00 in principal amount of the 13% Senior Secured Notes due 2007 that
are tendered pursuant to the tender offer.
A copy of the press release is attached as Exhibit 99.1 and
incorporated by reference into this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release issued July 17, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PHIBRO ANIMAL HEALTH CORPORATION
Dated: July 17, 2006 By: /s/ Richard C. Rosenzweig
--------------------------
Richard C. Rosenzweig
Senior Vice President
EXHIBIT INDEX
Exhibit No. Description
99.1 Press release issued July 17, 2006